PAPER Oueslati A, Schneider BL, Aebischer P, Lashuel HA
SEARCH RESULTS
331159 RESULTS
PAPER Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Immunology. 2013 Aug 24; PubMed: 23981039PAPER Ito K, Sano T, Kamiya K, Nakata Y, Shigemoto Y, Sato N, Oya Y, Matsuda H
Massive accumulation of 11C-Pittsburg compound B in the occipital lobes of a patient with early-onset dementia accompanied by muscle weakness and hypertonicity.
Ann Nucl Med. 2013 Aug 27; PubMed: 23982949PAPER Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, Borm GF, Dalaker TO, Beyer MK, Aarsland D, Andreasson U, Lange J, Tysnes OB, Zivadinov R, Larsen JP
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2013 May;84(5):537-43. PubMed: 23117496PAPER Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D
Changes in motor subtype and risk for incident dementia in Parkinson's disease.
Mov Disord. 2006 Aug;21(8):1123-30. PubMed: 16637023PAPER Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
J Neurol Neurosurg Psychiatry. 2006 May;77(5):585-9. PubMed: 16614017PAPER Saito T
[Amyloidogenicity and pathogenicity of Abeta43 in Alzheimer's disease].
Seikagaku. 2013 Jul;85(7):543-52. PubMed: 23980468PAPER Algarabel S, Fuentes M, Escudero J
On familiarity deficits in mild cognitive impairment: A reply to Migo and Westerberg.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2013 Aug 28; PubMed: 23980648PAPER Hou LN, Xu JR, Zhao QN, Gao XL, Cui YY, Xu J, Wang H, Chen HZ
A New Motif in the N-Terminal of Acetylcholinesterase Triggers Amyloid-β Aggregation and Deposition.
CNS Neurosci Ther. 2013 Aug 24; PubMed: 23981668PAPER Teplow DB
On the subject of rigor in the study of amyloid β-protein assembly.
Alzheimers Res Ther. 2013 Aug 27;5(4):39. PubMed: 23981712PAPER Rueeger H, Lueoend R, Machauer R, Veenstra SJ, Jacobson LH, Staufenbiel M, Desrayaud S, Rondeau JM, Möbitz H, Neumann U
Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: Structure based design and in vivo reduction of amyloid β-peptides.
Bioorg Med Chem Lett. 2013 Oct 1;23(19):5300-6. PubMed: 23981898PAPER Cui W, Tao J, Wang Z, Ren M, Zhang Y, Sun Y, Peng Y, Li R
Neuregulin1beta1 Antagonizes Apoptosis Via ErbB4-Dependent Activation of PI3-Kinase/Akt in APP/PS1 Transgenic Mice.
Neurochem Res. 2013 Nov;38(11):2237-46. PubMed: 23982319PAPER Islam MN, Khan RK, Rahman MM, Hayee MA, Jahan ME, Bhuiya MM
Etiological pattern of demented patients attending in a tertiary hospital.
Mymensingh Med J. 2013 Jul;22(3):496-503. PubMed: 23982539PAPER Braak H, Del Tredici K
Reply: the early pathological process in sporadic Alzheimer's disease.
Acta Neuropathol. 2013 Oct;126(4):615-8. PubMed: 23982593PAPER Katz DA, Liu W, Locke C, Jacobson P, Barnes DM, Basu R, An G, Rieser MJ, Daszkowski D, Groves F, Heneghan G, Shah A, Gevorkyan H, Jhee SS, Ereshefsky L, Marek GJ
Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384.
Transl Psychiatry. 2013 Aug 27;3:e295. PubMed: 23982627Current Filters
No filters selected